Vestor Capital LLC lifted its stake in CME Group Inc. (NASDAQ:CME - Free Report) by 463.2% in the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 5,086 shares of the financial services provider's stock after buying an additional 4,183 shares during the period. Vestor Capital LLC's holdings in CME Group were worth $1,071,000 at the end of the most recent reporting period.
A number of other institutional investors have also added to or reduced their stakes in the company. Stratos Wealth Partners LTD. increased its stake in CME Group by 4.7% in the third quarter. Stratos Wealth Partners LTD. now owns 2,452 shares of the financial services provider's stock valued at $491,000 after acquiring an additional 111 shares during the period. Brown Advisory Inc. grew its stake in shares of CME Group by 0.6% in the 3rd quarter. Brown Advisory Inc. now owns 15,237 shares of the financial services provider's stock valued at $3,051,000 after purchasing an additional 84 shares during the period. Mirae Asset Global Investments Co. Ltd. raised its holdings in shares of CME Group by 5.2% in the 3rd quarter. Mirae Asset Global Investments Co. Ltd. now owns 98,789 shares of the financial services provider's stock worth $19,780,000 after buying an additional 4,858 shares in the last quarter. Advisor Partners II LLC lifted its holdings in CME Group by 8.2% during the 3rd quarter. Advisor Partners II LLC now owns 18,230 shares of the financial services provider's stock valued at $3,650,000 after purchasing an additional 1,387 shares during the last quarter. Finally, Catalyst Financial Partners LLC boosted its position in CME Group by 18.4% in the third quarter. Catalyst Financial Partners LLC now owns 1,822 shares of the financial services provider's stock valued at $365,000 after buying an additional 283 shares in the last quarter. 87.75% of the stock is owned by institutional investors and hedge funds.
Insider Transactions at CME Group
In related news, insider Hilda Harris Piell sold 7,140 shares of the company's stock in a transaction that occurred on Wednesday, May 8th. The shares were sold at an average price of $210.35, for a total transaction of $1,501,899.00. Following the completion of the transaction, the insider now directly owns 29,256 shares in the company, valued at approximately $6,153,999.60. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. In other CME Group news, insider Hilda Harris Piell sold 7,140 shares of the stock in a transaction dated Wednesday, May 8th. The stock was sold at an average price of $210.35, for a total value of $1,501,899.00. Following the completion of the transaction, the insider now directly owns 29,256 shares in the company, valued at $6,153,999.60. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CEO Terrence A. Duffy sold 40,000 shares of the business's stock in a transaction dated Monday, April 29th. The stock was sold at an average price of $210.91, for a total value of $8,436,400.00. Following the sale, the chief executive officer now owns 67,455 shares in the company, valued at $14,226,934.05. The disclosure for this sale can be found here. 0.30% of the stock is owned by insiders.
Wall Street Analyst Weigh In
A number of research analysts recently issued reports on CME shares. JPMorgan Chase & Co. lifted their price target on CME Group from $198.00 to $206.00 and gave the company a "neutral" rating in a report on Thursday, April 25th. Morgan Stanley boosted their target price on CME Group from $222.00 to $225.00 and gave the stock an "equal weight" rating in a research report on Tuesday, April 9th. Deutsche Bank Aktiengesellschaft reiterated a "hold" rating and issued a $210.00 price target (down from $235.00) on shares of CME Group in a research report on Friday, April 5th. Bank of America upped their target price on shares of CME Group from $209.00 to $216.00 and gave the company a "neutral" rating in a research note on Thursday, April 25th. Finally, Barclays lifted their price target on shares of CME Group from $226.00 to $228.00 and gave the stock an "equal weight" rating in a research report on Thursday, April 25th. Two research analysts have rated the stock with a sell rating, seven have issued a hold rating and two have assigned a buy rating to the stock. Based on data from MarketBeat, the company currently has an average rating of "Hold" and a consensus target price of $217.80.
Get Our Latest Report on CME
CME Group Stock Performance
Shares of NASDAQ:CME traded down $5.15 on Friday, reaching $208.46. 1,838,745 shares of the company's stock were exchanged, compared to its average volume of 1,789,432. CME Group Inc. has a twelve month low of $175.73 and a twelve month high of $223.80. The company has a fifty day moving average of $213.33 and a 200-day moving average of $211.44. The company has a market capitalization of $75.04 billion, a price-to-earnings ratio of 24.04, a PEG ratio of 5.19 and a beta of 0.48. The company has a current ratio of 1.01, a quick ratio of 1.01 and a debt-to-equity ratio of 0.10.
CME Group (NASDAQ:CME - Get Free Report) last released its earnings results on Wednesday, April 24th. The financial services provider reported $2.50 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.44 by $0.06. The company had revenue of $1.49 billion for the quarter, compared to analyst estimates of $1.48 billion. CME Group had a return on equity of 12.45% and a net margin of 56.84%. CME Group's quarterly revenue was up 3.2% on a year-over-year basis. During the same period in the prior year, the firm posted $2.42 EPS. On average, research analysts predict that CME Group Inc. will post 9.72 EPS for the current fiscal year.
CME Group Dividend Announcement
The firm also recently declared a quarterly dividend, which will be paid on Tuesday, June 25th. Stockholders of record on Friday, June 7th will be paid a $1.15 dividend. The ex-dividend date of this dividend is Friday, June 7th. This represents a $4.60 annualized dividend and a dividend yield of 2.21%. CME Group's payout ratio is 52.33%.
CME Group Profile
(
Free Report)
CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.
Read More
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider CME Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and CME Group wasn't on the list.
While CME Group currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking to avoid the hassle of mudslinging, volatility, and uncertainty? You'd need to be out of the market, which isn’t viable. So where should investors put their money? Find out with this report.
Get This Free Report
